1,200
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

Long Noncoding RNA NONHSAT177112.1 Aggravates Inflammation and Apoptosis in LPS-Treated Human Cardiomyocytes

, , ORCID Icon, , , , & show all
Pages 411-422 | Received 04 Sep 2020, Accepted 29 Jan 2021, Published online: 01 Mar 2021

References

  • Buggey J , ElAmmCA. Myocarditis and cardiomyopathy. Curr. Opin. Cardiol.33(3), 341–346 (2018).
  • Dasgupta S , IannucciG , MaoCet al. Myocarditis in the pediatric population: a review. Congenit. Heart. Dis.14(5), 868–877 (2019).
  • Ali-Ahmed F , DalgaardF , Al-KhatibSM. Sudden cardiac death in patients with myocarditis: evaluation, risk stratification, and management. Am. Heart. J.220, 29–40 (2019).
  • Kindermann I , BarthC , MahfoudFet al. Update on myocarditis. J. Am. Coll. Cardiol.59(9), 779–792 (2012).
  • Bracamonte-Baran W , ČihákováD. Cardiac autoimmunity myocarditis. Adv. Exp. Med. Biol.1003, 187–221 (2017).
  • Jensen LD , MarchantDJ. Emerging pharmacologic targets and treatments for myocarditis. Pharmacol. Ther.161, 40–51 (2016).
  • Hua X , SongJ. Immune cell diversity contributes to the pathogenesis of myocarditis. Heart. Fail. Rev.24(6), 1019–1030 (2019).
  • Vdovenko D , ErikssonU. Regulatory role of CD4 + T cells in myocarditis. J. Immunol. Res.2018, 4396311–4396351 (2018).
  • Zhang Z , SalisburyD , SallamT. Long noncoding RNAs in atherosclerosis: JACC review topic of the week. J. Am. Coll. Cardiol.72(19), 2380–2390 (2018).
  • Zhang X , WangW , ZhuWet al. Mechanisms and functions of long non-coding RNAs at multiple regulatory levels. Int. J. Mol. Sci.20(22), 5573 (2019).
  • Devaux Y , ZangrandoJ , SchroenBet al. Long noncoding RNAs in cardiac development and ageing. Nat. Rev. Cardiol.12(7), 415–425 (2015).
  • Zhang Y , DuW , YangB. Long non-coding RNAs as new regulators of cardiac electrophysiology and arrhythmias: molecular mechanisms, therapeutic implications and challenges. Pharmacol. Ther.203, 107389 (2019).
  • Das S , SenapatiP , ChenZet al. Regulation of angiotensin II actions by enhancers and super-enhancers in vascular smooth muscle cells. Nat. Commun.8(1), 1467 (2017).
  • Jin L , LinX , YangLet al. AK098656, a novel vascular smooth muscle cell-dominant long noncoding RNA, promotes hypertension. Hypertension.71(2), 262–272 (2018).
  • Scheuermann JC , BoyerLA. Getting to the heart of the matter: long non-coding RNAs in cardiac development and disease. EMBO. J.32(13), 1805–1816 (2013).
  • Rizki G , BoyerLA. Lncing epigenetic control of transcription to cardiovascular development and disease. Circ. Res.117(2), 192–206 (2015).
  • Cremer S , MichalikK , FischerA. Hematopoietic deficiency of the long non-coding RNA MALAT1 promotes atherosclerosis and plaque inflammation. Circulation139(10), 1320–1334 (2018).
  • Das S , ZhangE , SenapatiPet al. A novel angiotensin II-induced long noncoding RNA giver regulates oxidative stress, inflammation, and proliferation in vascular smooth muscle cells. Circ. Res.123(12), 1298–1312 (2018).
  • Zhang Y , SunL , XuanLet al. Long non-coding RNA CCRR controls cardiac conduction via regulating intercellular coupling. Nat. Commun.9(1), 4176 (2018).
  • Long QQ , WangH , GaoWet al. Long noncoding RNA Kcna2 antisense RNA contributes to ventricular arrhythmias via silencing Kcna2 in rats with congestive heart failure. J. Am. Heart. Assoc.6(12), e005965 (2017).
  • Liu Q , KongY , HanBet al. Long non-coding RNA expression profile and functional analysis in children with acute fulminant myocarditis. Front. Pediatr.7, 283 (2019).
  • Zhang N , SunY. LncRNA ROR facilitates myocardial fibrosis in rats with viral myocarditis through regulating C-Myc expression. Eur. Rev. Med. Pharmacol. Sci.23(24), 10982–10988 (2019).
  • Vervliet T , RobinsonEL , RoderickHL. Lnc’ing Ca(2+), SERCA and cardiac disease. Cell Calcium.72, 132–134 (2018).
  • Cai B , MaW , DingFet al. The long noncoding RNA CAREL controls cardiac regeneration. J. Am. Coll. Cardiol.72(5), 534–550 (2018).
  • Woudstra L , JuffermansLJM , van RossumACet al. Infectious myocarditis the role of the cardiac vasculature. Heart. Fail. Rev.23(4), 583–595 (2018).
  • Yu B , WangS. Angio-LncRs: LncRNAs that regulate angiogenesis and vascular disease. Theranostics.8(13), 3654–3675 (2018).
  • Rose NR . Viral myocarditis. Curr. Opin. Rheumatol.28(4), 383–389 (2016).
  • Martens L , RuhleF , StollM. LncRNA secondary structure in the cardiovascular system. Noncoding RNA Res.2(3-4), 137–142 (2017).
  • Weinzierl AO , SzalayG , WolburgHet al. Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4−/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis. J. Virol.82(16), 8149–8160 (2008).
  • Onyimba JA , CoronadoMJ , GartonAEet al. The innate immune response to coxsackievirus B3 predicts progression to cardiovascular disease and heart failure in male mice. Biol. Sex. Differ.2, 2 (2011).
  • Yucel G , ZhaoZ , El-BattrawyIet al. Lipopolysaccharides induced inflammatory responses and electrophysiological dysfunctions in human-induced pluripotent stem cell derived cardiomyocytes. Sci. Rep.7(1), 2935 (2017).
  • Nishii M , InomataT , TakehanaHet al. Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis. J. Am. Coll. Cardiol.44(6), 1292–1297 (2004).